<DOC>
	<DOCNO>NCT01670656</DOCNO>
	<brief_summary>The study investigate four vaginal ring group respect relief primary dysmenorrhea , identify least one vaginal ring show clinically relevant treatment efficacy relief primary dysmenorrhea .</brief_summary>
	<brief_title>A Study Evaluate Effect Vaginal Rings Primary Dysmenorrhea ( P08257/MK-8175A/MK-8342B-057 )</brief_title>
	<detailed_description>The study investigate four vaginal ring group respect relief primary dysmenorrhea , identify least one vaginal ring show clinically relevant treatment efficacy relief primary dysmenorrhea . The intake ibuprofen rescue medication impact daily life investigate : change baseline data two variable compare four active ring group , separately , placebo ring group . Furthermore , study ass measurement characteristic psychometric property newly develop Dysmenorrhea Daily Dairy . Vaginal bleeding pattern general safety tolerability also evaluate .</detailed_description>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Body mass index ( BMI ) ≥18 ≤35 Established diagnosis primary dysmenorrhea If childbearing potential must agree use condom contraception entire screening period , treatment period , posttreatment period final study visit , unless partner surgically sterilize Agree stop use hormonal contraceptive ( combine progestinonly ) , non hormonal intrauterine device ( IUD ) Regular menstrual cycle range 24 35 day length Any following contraindication use contraceptive steroid include : presence history venous arterial thrombotic/thromboembolic event cerebrovascular accident ( stroke , history migraine focal neurological symptom , diabetes mellitus vascular involvement , severe multiple risk factor ( ) venous arterial thrombosis , severe dyslipoproteinemia , severe hypertension , pancreatitis history thereof associate severe hypertriglyceridaemia , presence history severe hepatic ( liver ) disease , include benign malignant tumor , know suspect sex steroidinfluenced malignancy , and/or undiagnosed vaginal bleeding Pregnant breastfeeding Secondary dysmenorrhea Has spontaneous menstruation follow delivery abortion Participated investigational drug study within 30 day History malignancy ≤5 year Documented abnormal cervical smear result within 6 month Use recreational illicit drug Consumes &gt; 2 alcoholic drink per day &gt; 14 alcoholic drink per week , engage binge drink Allergy/sensitivity ibuprofen , contraindication use , experience asthma , urticaria , allergictype reaction take aspirin , nonsteroidal anti inflammatory drug Has sterilize use fallopian tube occlusion device Is receive , receive sex hormone purpose contraception within 2 month injectable hormonal contraception within 6 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>